title: Effects of selective and non-selective phosphodiesterase inhibitors on tracheal mucus secretion in the rat.
abstract: The present study was designed to characterize the effects of unselective and isoenzyme-selective phosphodiesterase inhibitors on airway mucus secretion. The isolated rat trachea was incubated in a modified Ussing chamber. Mucus macromolecules were metabolically labelled with 35S. The inhibitors were applied at the luminal side. The unselective phosphodiesterase inhibitors theophylline, enprofylline and 3-isobutyl-methylxanthine stimulated mucus secretion in a concentration-dependent manner with half-maximum effects (EC50 values) at 690 microM, 400 microM and 46 microM, respectively. The adenosine antagonist 8-phenyltheophylline did not significantly stimulate mucus output, suggesting a negligible role of adenosine in the cellular mechanisms of mucus secretion. Adenosine itself did not increase radiolabel output. Rolipram, an inhibitor of phosphodiesterase isoenzyme IV, and zardaverine, which inhibits the isoenzymes III and IV, increased potently macromolecule output with EC50 values of 40 nM and 6 microM, respectively. The selective inhibitors of phosphodiesterase isoenzymes III and V, motapizone and zaprinast, did not influence airway mucus release, suggesting a relatively low activity of isoenzymes III and V in glands of rat trachea. The stimulatory effect of theophylline on airway mucus secretion may contribute to its beneficial action in chronic obstructive airway disease. Our data suggest that this effect is mediated predominantly by phosphodiesterase isoenzyme IV.
authors.affiliation: Department of Internal Medicine, Philipps-University, Marburg/Lahn, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Wagner
authors.forename: D
authors.initials: D
authors.lastname: Bredenbröker
authors.forename: H C
authors.initials: HC
authors.lastname: Fehmann
authors.forename: F
authors.initials: F
authors.lastname: Schwarz
authors.forename: C
authors.initials: C
authors.lastname: Schudt
authors.forename: P
authors.initials: P
authors.lastname: Von Wichert
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D066298:In Vitro Techniques; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism; D008297:Male; D009093:Mucus / Q000378:metabolism*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology; D014132:Trachea / Q000187:drug effects / Q000378:metabolism*; D014970:Xanthines / Q000494:pharmacology
chemical_list: D007527:Isoenzymes; D010726:Phosphodiesterase Inhibitors; D014970:Xanthines; D013806:Theophylline; C034347:enprofylline; D010727:Phosphoric Diester Hydrolases; D015056:1-Methyl-3-isobutylxanthine